A new U.S. study offers more evidence that a single dose of a two-dose COVID-19 vaccine may provide enough protection to people who've previously been infected with the coronavirus. "Our findings extend those from smaller studies reported elsewhere and support a potential strategy of providing a single dose of vaccine to persons with a confirmed prior history of coronavirus infection, along with two doses for people not previously infected," said researcher Dr. Susan Cheng.